Innovating Works
PROTECT: PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccine Trials in Africa (PROTECT) LINQ MANAGEMENT GMBH participó en un HORIZON EUROPE HORIZON-JU-GH-EDCTP3-2023-01 Two vaccines designed for pregnant women, to protect their unborn infant, are entering late phase development and will prevent infections fr...
2024-02-27 - 2027-02-28 | Financiado
GenPath Africa: GENOMIC SURVEILLANCE TO CONTROL PATHOGEN INFECTIONS IN AFRICA LINQ MANAGEMENT GMBH participó en un HORIZON EUROPE HORIZON-JU-GH-EDCTP3-2022-01 The overall goal of GenPath Africa is to control pathogen infections in Africa. Our consortium of African and European investigators propose...
2023-08-28 - 2027-04-30 | Financiado
MARC SE-Africa: Mitigating Antimalarial Resistance Consortium in South East Africa LINQ MANAGEMENT GMBH participó en un HORIZON EUROPE HORIZON-JU-GH-EDCTP3-2022-01 BACKGROUND: Gains achieved in reducing the burden of malaria and advancing its elimination are now threatened by the independent emergence a...
2023-03-31 - 2027-03-31 | Financiado
ESPACE: Human Cell Atlas of the Pancreas LINQ MANAGEMENT GMBH participó en un H2020 H2020-SC1-BHC-2018-2020 The human pancreas is a physiologically unique organ involved in the secretion of several hormones, such as insulin, thus regulating blood s...
2019-12-13 - 2022-06-30 | Financiado
EUCANCan: EUCANCan a federated network of aligned and interoperable infrastructures for the homogeneous analy... LINQ MANAGEMENT GMBH participó en un H2020 H2020-SC1-BHC-2018-2020 We propose to create the EUropean-CANadian Cancer network (EUCANCan), a federated infrastructure whose mission is to enable Personalized Med...
2018-12-04 - 2023-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.